PAULINA SWIETLIK: Open Payments
NPI 1922321504 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 20 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $708 · 2025 $921
Food & beverage: $821Education: $100
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 2 | $226 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $158 |
| UCB, Inc. | 2 | $149 |
| Janssen Biotech, Inc. | 1 | $125 |
| Incyte Corporation | 5 | $122 |
| GENZYME CORPORATION | 1 | $31 |
| Organon LLC | 1 | $27 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $21 |
Products named: NEMLUVIO, Bimzelx, TREMFYA, OPZELURA, Winlevi, DUPIXENT, Zoryve, SKYRIZI.
Industry payments across NY — which companies pay providers there.
